Clinical trial Recruiting at 2 sites Interventional Ages 18 to 80

Robot-assisted closed reduction and fixation for distal femur fractures

Official title: Key Technology Research and Development for Intelligent Minimally Invasive Precision Treatment of Fractures (Sub-project 3: A Randomized Controlled Trial of Robot-Assisted Closed Reduction and Internal Fixation for Supracondylar Femoral Fractures)

Run by Beijing Jishuitan Hospital · NCT07738406 · Data updated 2026-11-12

This study tests whether a smart robotic system can help doctors realign extra-articular supracondylar femur fractures more precisely and with less radiation than conventional methods in adults aged 18–80.

More Femoral Neck Fractures trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment80 (estimated)
SponsorBeijing Jishuitan Hospital
Academic / other
Drugs / interventionsradiation
Locations2 sites (Beijing, Beijing Municipality and 1 other locations)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedJuly 31, 2026
Trial IDNCT07738406 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–80 with unilateral acute closed extra-articular supracondylar femoral fractures (AO/OTA 33-A) eligible for surgical reduction.

Probably not a fit

Patients with open fractures, multiple traumas, prior femur deformities, or other conditions that preclude standard evaluation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial compares robot-assisted closed reduction with traditional surgeon-led reduction for supracondylar femoral fractures (AO/OTA 33-A). The study aims to determine if the robotic system improves anatomical alignment and functional recovery while reducing radiation exposure from fluoroscopy. Participants are adults with acute unilateral closed fractures, eligible if surgery can occur within 21 days and they can walk independently before injury. The trial will assess safety and efficacy of the robotic approach versus conventional fixation. No phase designation is reported.

Why it matters

Potential benefit: If successful, patients may experience more accurate bone alignment, better functional outcomes, and less radiation exposure during surgery.

How similar studies have gone: Prior studies in robotic fracture reduction have shown promise in improving alignment, but evidence remains variable and this trial adds contemporary, automated guidance.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 80 years old
* Unilateral, acute, closed extra-articular supracondylar femoral fracture (Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association AO/OTA 33-A)
* Time from injury to surgery ≤21 days
* Able to walk independently before injury (assistive devices allowed)

Exclusion Criteria:

* Open fractures or multiple severe traumas requiring priority treatment
* Asymmetrical lower extremities, or prior malunion of the ipsilateral femur, or pre-existing deformities significantly affecting rotation/length evaluation
* Unilateral fractures combined with other sites
* Pathological fractures (tumor or metabolic)
* Prior complex implants in place or previous surgeries significantly affecting evaluation
* Active infection or severe systemic medical contraindications (unable to tolerate anesthesia/surgery)
* Cognitive impairment, poor compliance, pregnancy, or lactation
* Deemed unsuitable by the investigator (e.g., unable to follow up, or extreme obesity severely limiting the surgical or robotic workspace)
* Refused randomization or enrollment

Where it's running

  • Aerospace Center Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • Beijing Jishuitan Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.